Haleon plc (NYSE:HLN) Shares Acquired by Fmr LLC

FMR LLC raised its stake in Haleon plc (NYSE:HLN - Free Report) by 5.8% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 104,918,269 shares of the company's stock after acquiring an additional 5,768,117 shares during the period. FMR LLC owned 2.32% of Haleon worth $1,110,035,000 as of its most recent SEC filing.

Several other institutional investors also recently made changes to their positions in HLN. Fortitude Family Office LLC acquired a new position in Haleon during the 3rd quarter valued at approximately $28,000. Cultivar Capital Inc. acquired a new stake in shares of Haleon in the 2nd quarter worth about $40,000. Hexagon Capital Partners LLC increased its holdings in shares of Haleon by 66.6% in the 2nd quarter. Hexagon Capital Partners LLC now owns 6,695 shares of the company's stock worth $55,000 after acquiring an additional 2,677 shares during the period. Prospera Private Wealth LLC bought a new stake in Haleon in the 3rd quarter valued at about $57,000. Finally, BOKF NA boosted its stake in Haleon by 68.8% during the 2nd quarter. BOKF NA now owns 6,972 shares of the company's stock valued at $58,000 after purchasing an additional 2,842 shares during the period. 6.67% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

HLN has been the topic of several analyst reports. The Goldman Sachs Group lowered shares of Haleon from a "buy" rating to a "neutral" rating in a research note on Tuesday, August 6th. Berenberg Bank started coverage on Haleon in a research report on Tuesday, August 6th. They set a "buy" rating for the company. UBS Group raised Haleon to a "strong-buy" rating in a report on Tuesday, October 1st. Finally, Morgan Stanley lifted their price objective on shares of Haleon from $9.90 to $10.95 and gave the company an "overweight" rating in a research note on Friday, September 20th. One equities research analyst has rated the stock with a hold rating, four have assigned a buy rating and one has assigned a strong buy rating to the company's stock. According to MarketBeat.com, the company presently has a consensus rating of "Buy" and a consensus target price of $10.95.

Haleon Price Performance

Shares of NYSE HLN traded up $0.13 during mid-day trading on Thursday, reaching $9.72. 5,935,717 shares of the company traded hands, compared to its average volume of 5,314,855. Haleon plc has a fifty-two week low of $7.89 and a fifty-two week high of $10.80. The firm has a market cap of $44.00 billion, a PE ratio of 28.60, a price-to-earnings-growth ratio of 2.89 and a beta of 0.30. The stock has a fifty day simple moving average of $9.95 and a 200-day simple moving average of $9.41. The company has a debt-to-equity ratio of 0.44, a current ratio of 0.84 and a quick ratio of 0.58.

Haleon Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.